MRK.N (MRK.N) News
Track canonical SquawkNews coverage tagged to MRK.N, MRK.N. This hub brings together deduplicated headlines about market instrument, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 5 indexed stories across 2 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
Merck says EU CHMP backs Keytruda — Padcev perioperative use in muscle — invasive bladder cancer
EU CHMP backed Keytruda with Padcev for perioperative use in resectable muscle-invasive bladder cancer; European Commission decision due in Q4 2026. Recommendation follows Phase 3 KEYNOTE-B15, showing event-free survival
NEWS | Sep 18, 2026, 10:57 AM UTC
L
Merck says EU CHMP backs Keytruda — Padcev perioperative use in resectable muscle — invasive bladder cancer
Merck reported Phase 3 KEYNOTE-B15 results supporting perioperative Keytruda with Padcev in resectable muscle-invasive bladder cancer. Results were already reported in the CHMP briefing; no future scientific meeting pres
NEWS | Sep 18, 2026, 10:57 AM UTC
H
Merck Receives Positive EU CHMP Opinion for KEYTRUDA® (pembrolizumab) Plus Padcev® (enfortumab vedotin — ejfv) as Perioperative Treatment for Adults With Resectable Muscle — Invasive Bladder Cancer (MIBC)
For best results when printing this announcement, please click on link below: Merck Receives Positive EU CHMP Opinion for KEYTRUDA(®) (pembrolizumab) Plus Padcev(®) (enfortumab vedotin-ejfv) as Perioperative Treatment fo
CENTRAL_BANK | Sep 18, 2026, 10:57 AM UTC
H
Merck Launches Your Hive of Whole Health to Support Whole Person Care for People Living With HIV
For best results when printing this announcement, please click on link below: Merck Launches Your Hive of Whole Health to Support Whole Person Care for People Living With HIV Debbie Allen, famed actress, director, produc
CENTRAL_BANK | Sep 18, 2026, 10:47 AM UTC
M
US stocks close higher; Moderna surges, Merck and Marvell gain
US stocks closed higher Wednesday, with the Dow Jones Industrial Average up 0.22%, the S&P 500 up 0.21% and the Nasdaq up 0.16%, while Moderna surged 176% and Merck and Marvell also advanced.
EQUITY | Aug 19, 2026, 08:05 PM UTC